Physician profile
Nora M Margolis
NPI 1629134408
$6,410.17
in general payments reported to CMS, 2019-2025
17 companies · $1,115 in 2025
The $1,115 reported for 2025 was more than what 83% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $833 · 2020: $271 · 2021: $827 · 2022: $939 · 2023: $1,255 · 2024: $1,170 · 2025: $1,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,539.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,794.53 | 2019-2025 | Qelbree, Qelbree |
| Abbvie INC. | $1,636.90 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $623.13 | 2020-2025 | Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $419.22 | 2019-2025 | Ingrezza |
| Corium, LLC | $405.12 | 2023-2024 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $374.10 | 2021-2025 | Caplyta |
| Ironshore Pharmaceuticals INC. | $336.38 | 2019-2024 | Jornay Pm |
| Allergan, INC. | $182.39 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $151.78 | 2019-2020 | |
| Lundbeck LLC | $100.28 | 2021-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $98.40 | 2019-2025 | Fanapt |
| Shire North American Group INC | $87.57 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $61.26 | 2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $57.30 | 2019 | |
| Axsome Therapeutics, INC. | $44.61 | 2024 | Auvelity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $23.67 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Margolis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.